Company-level financial information

WEST PHARMACEUTICAL SERVICES INC

Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.

Annual net income

Reported annual periods; USD. Negative values extend below the baseline.

Selected annual US-GAAP cash-flow and earnings facts · USD
Reporting period	Measure	USD millions	Filing
Dec 31, 2025From Jan 1, 2025	Operating cash flow	754.8	SEC filingFeb 17, 2026
Dec 31, 2025From Jan 1, 2025	Net income	493.7	SEC filingFeb 17, 2026
Dec 31, 2025From Jan 1, 2025	Common-stock cash dividends	61.2	SEC filingFeb 17, 2026
Dec 31, 2025From Jan 1, 2025	Capital expenditures (PP&E)	285.9	SEC filingFeb 17, 2026
Dec 31, 2024From Jan 1, 2024	Operating cash flow	653.4	SEC filingFeb 17, 2026
Dec 31, 2024From Jan 1, 2024	Net income	492.7	SEC filingFeb 17, 2026
Dec 31, 2024From Jan 1, 2024	Common-stock cash dividends	59.1	SEC filingFeb 17, 2026
Dec 31, 2024From Jan 1, 2024	Capital expenditures (PP&E)	377.0	SEC filingFeb 17, 2026
Dec 31, 2023From Jan 1, 2023	Operating cash flow	776.5	SEC filingFeb 17, 2026
Dec 31, 2023From Jan 1, 2023	Net income	593.4	SEC filingFeb 17, 2026
Dec 31, 2023From Jan 1, 2023	Common-stock cash dividends	57.0	SEC filingFeb 17, 2026
Dec 31, 2023From Jan 1, 2023	Capital expenditures (PP&E)	362.0	SEC filingFeb 17, 2026
Dec 31, 2022From Jan 1, 2022	Operating cash flow	724.0	SEC filingFeb 18, 2025
Dec 31, 2022From Jan 1, 2022	Net income	585.9	SEC filingFeb 18, 2025
Dec 31, 2022From Jan 1, 2022	Common-stock cash dividends	54.1	SEC filingFeb 18, 2025
Dec 31, 2022From Jan 1, 2022	Capital expenditures (PP&E)	284.6	SEC filingFeb 18, 2025
Dec 31, 2021From Jan 1, 2021	Operating cash flow	584.0	SEC filingFeb 20, 2024
Dec 31, 2021From Jan 1, 2021	Net income	661.8	SEC filingFeb 20, 2024
Dec 31, 2021From Jan 1, 2021	Common-stock cash dividends	51.1	SEC filingFeb 20, 2024
Dec 31, 2021From Jan 1, 2021	Capital expenditures (PP&E)	253.4	SEC filingFeb 20, 2024
Dec 31, 2020From Jan 1, 2020	Operating cash flow	472.5	SEC filingFeb 21, 2023
Dec 31, 2020From Jan 1, 2020	Net income	346.2	SEC filingFeb 21, 2023
Dec 31, 2020From Jan 1, 2020	Common-stock cash dividends	48.1	SEC filingFeb 21, 2023
Dec 31, 2020From Jan 1, 2020	Capital expenditures (PP&E)	174.4	SEC filingFeb 21, 2023
Dec 31, 2019From Jan 1, 2019	Operating cash flow	367.2	SEC filingFeb 22, 2022
Dec 31, 2019From Jan 1, 2019	Net income	241.7	SEC filingFeb 22, 2022
Dec 31, 2019From Jan 1, 2019	Common-stock cash dividends	45.1	SEC filingFeb 22, 2022
Dec 31, 2019From Jan 1, 2019	Capital expenditures (PP&E)	126.4	SEC filingFeb 22, 2022

Latest filed value per tag and exact annual period, within the last seven years. Common-stock and total cash dividends are separate measures; do not add them together. These selected facts are not a complete financial statement.